Selectively isolate beta-hemolytic group A streptococci from throat cultures and upper respiratory specimens using Thermo Scientific™ Remel™ SXT Blood Agar
Pacifico at al
demonstrated the isolation of β-hemolyic streptococci is improved with the use of a selective medium which inhibits oropharyngeal commensal microbial flora 1
In 1977, Gunn et al
introduced a selective medium containing sulfamethoxazole and trimethoprim in a tryptic soy agar base supplemented with 5% sheep blood 2
In 1979, Kurzynski et al
proved that streptococci were more frequently isolated on SXT sheep blood agar 3
Clinical assessment alone is unreliable in distinguishing streptococcal and non-streptococcol pharyngitis 4
Serious medical complications may follow pharyngitis caused by group A streptococci, making bacterial examination of the throat an indispensable diagnostic tool
Use of SXT sheep blood agar allows enhanced recovery of Lancefield groups A and B streptococci from throat cultures while inhibiting the growth of commensal microbial flora
Ready-to-use – The convenience of prepared media Selective – Use of sulfamethoxazole plus trimethoprim (SXT) supresses growth of streptococcal groups C, F, and G and Streptococci viridans , most Enterobacteriaceae, Neisseria , and some Pseudomonas This medium contains casein and soy peptones that provide nutritious source of nitrogen, amino acids, and peptides
Sheep blood provides growth factors and allows detection of hemolytic reactions
Sodium chloride maintains osmotic equilibrium
SXT (sulfamethoxazole, trimethoprim) act as selective agents to supresse most commensal microbial flora found in the oropharynx, including streptococcal groups C, F, and G and Streptococci viridans , most Enterobacteriaceae, Neisseria , and some Pseudomonas spp
Not all products are available for sale in all territories
Please inquire
Remel™ and Oxoid™ products are now part of the Thermo Scientific brand.